Depreciation of Evelo Biosciences, Inc. from 31 Dec 2016 to 30 Sep 2023

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Evelo Biosciences, Inc. quarterly and annual Depreciation in USD history and change rate from 31 Dec 2016 to 30 Sep 2023.
  • Evelo Biosciences, Inc. Depreciation for the quarter ending 30 Sep 2023 was $200,000, a 60% decline year-over-year.
  • Evelo Biosciences, Inc. Depreciation for the twelve months ending 30 Sep 2023 was $1,588,000, a 24% decline year-over-year.
  • Evelo Biosciences, Inc. annual Depreciation for 2022 was $2,060,000, a 7% decline from 2021.
  • Evelo Biosciences, Inc. annual Depreciation for 2021 was $2,216,000, a 9.4% increase from 2020.
  • Evelo Biosciences, Inc. annual Depreciation for 2020 was $2,026,000, a 15% increase from 2019.
Source SEC data
View on sec.gov
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Change (%)
Depreciation, Annual (USD)
Depreciation, YoY Annual Change (%)

Evelo Biosciences, Inc. Quarterly Depreciation (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2023 $1,588,000 $200,000 -$300,000 -60% 01 Jul 2023 30 Sep 2023 10-Q 09 Nov 2023 2023 Q3
Q2 2023 $1,888,000 $400,000 -$100,000 -20% 01 Apr 2023 30 Jun 2023 10-Q 14 Aug 2023 2023 Q2
Q1 2023 $1,988,000 $445,000 -$72,000 -14% 01 Jan 2023 31 Mar 2023 10-Q 15 May 2023 2023 Q1
Q4 2022 $2,060,000 $543,000 -$37,000 -6.4% 01 Oct 2022 31 Dec 2022 10-K 16 Mar 2023 2022 FY
Q3 2022 $2,097,000 $500,000 -$100,000 -17% 01 Jul 2022 30 Sep 2022 10-Q 09 Nov 2023 2023 Q3
Q2 2022 $2,197,000 $500,000 $0 0% 01 Apr 2022 30 Jun 2022 10-Q 14 Aug 2023 2023 Q2
Q1 2022 $2,197,000 $517,000 -$19,000 -3.5% 01 Jan 2022 31 Mar 2022 10-Q 15 May 2023 2023 Q1
Q4 2021 $2,216,000 $580,000 +$45,000 +8.4% 01 Oct 2021 31 Dec 2021 10-K 16 Mar 2023 2022 FY
Q3 2021 $2,171,000 $600,000 +$100,000 +20% 01 Jul 2021 30 Sep 2021 10-Q/A 29 Oct 2021 2021 Q3
Q2 2021 $2,071,000 $500,000 $0 0% 01 Apr 2021 30 Jun 2021 10-Q 11 Aug 2022 2022 Q2
Q1 2021 $2,071,000 $536,000 +$45,000 +9.2% 01 Jan 2021 31 Mar 2021 10-Q 12 May 2022 2022 Q1
Q4 2020 $2,026,000 $535,000 +$46,000 +9.4% 01 Oct 2020 31 Dec 2020 10-K 24 Mar 2022 2021 FY
Q3 2020 $1,980,000 $500,000 $0 0% 01 Jul 2020 30 Sep 2020 10-Q/A 29 Oct 2021 2021 Q3
Q2 2020 $1,980,000 $500,000 +$100,000 +25% 01 Apr 2020 30 Jun 2020 10-Q 29 Jul 2021 2021 Q2
Q1 2020 $1,880,000 $491,000 +$116,000 +31% 01 Jan 2020 31 Mar 2020 10-Q 29 Apr 2021 2021 Q1
Q4 2019 $1,764,000 $489,000 +$139,000 +40% 01 Oct 2019 31 Dec 2019 10-K 09 Mar 2021 2020 FY
Q3 2019 $1,625,000 $500,000 +$200,000 +67% 01 Jul 2019 30 Sep 2019 10-Q 30 Oct 2020 2020 Q3
Q2 2019 $1,425,000 $400,000 -$300,000 -43% 01 Apr 2019 30 Jun 2019 10-Q 31 Jul 2020 2020 Q2
Q1 2019 $1,725,000 $375,000 -$210,000 -36% 01 Jan 2019 31 Mar 2019 10-Q 11 May 2020 2020 Q1
Q4 2018 $1,935,000 $350,000 +$79,000 +29% 01 Oct 2018 31 Dec 2018 10-K 14 Feb 2020 2019 FY
Q3 2018 $1,856,000 $300,000 +$100,000 +50% 01 Jul 2018 30 Sep 2018 10-Q 05 Nov 2019 2019 Q3
Q2 2018 $1,756,000 $700,000 +$500,000 +250% 01 Apr 2018 30 Jun 2018 10-Q 06 Aug 2019 2019 Q2
Q1 2018 $1,256,000 $585,000 +$422,000 +259% 01 Jan 2018 31 Mar 2018 10-Q 03 May 2019 2019 Q1
Q4 2017 $834,000 $271,000 01 Oct 2017 31 Dec 2017 10-K 14 Feb 2020 2019 FY
Q3 2017 $200,000 01 Jul 2017 30 Sep 2017 10-Q 02 Nov 2018 2018 Q3
Q2 2017 $200,000 01 Apr 2017 30 Jun 2017 10-Q 02 Aug 2018 2018 Q2
Q1 2017 $163,000 01 Jan 2017 31 Mar 2017 10-Q 31 May 2018 2018 Q1

Evelo Biosciences, Inc. Annual Depreciation (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2022 $2,060,000 -$156,000 -7% 01 Jan 2022 31 Dec 2022 10-K 16 Mar 2023 2022 FY
2021 $2,216,000 +$190,000 +9.4% 01 Jan 2021 31 Dec 2021 10-K 16 Mar 2023 2022 FY
2020 $2,026,000 +$262,000 +15% 01 Jan 2020 31 Dec 2020 10-K 24 Mar 2022 2021 FY
2019 $1,764,000 -$171,000 -8.8% 01 Jan 2019 31 Dec 2019 10-K 09 Mar 2021 2020 FY
2018 $1,935,000 +$1,101,000 +132% 01 Jan 2018 31 Dec 2018 10-K 14 Feb 2020 2019 FY
2017 $834,000 +$339,000 +68% 01 Jan 2017 31 Dec 2017 10-K 14 Feb 2020 2019 FY
2016 $495,000 01 Jan 2016 31 Dec 2016 10-K 15 Feb 2019 2018 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.